Above photo obtained from PATH/Satvir Malhotra. A worker at Serum Institute of India inspects vaccine vials at the company’s vaccine manufacturing division where PNEUMOSIL® and other conjugate vaccines are made.
A Comment from the Coordinator
Happy new year from the Pneumonia Innovations Network (PIN)! Some exciting news to greet the new year. After over a decade of development and research, Serum Institute of India’s PNEUMOSIL®, a new and highly anticipated 10-valent pneumococcal conjugate vaccine has received World Health Organization pre-qualification with a target price of US$2 per dose.